Free Trial

Merck & Co., Inc. (MRK) SEC Filings & 10K Form

Merck & Co., Inc. logo
$86.32 -0.28 (-0.32%)
Closing price 04/3/2025 03:59 PM Eastern
Extended Trading
$85.84 -0.49 (-0.56%)
As of 04:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Merck & Co., Inc. SEC Filings

DateFilerForm TypeView
04/02/2025
8:57 AM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
8:50 AM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
8:53 AM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
1:08 PM
Merck & Co., Inc. (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
02/19/2025
4:09 PM
Merck & Co., Inc. (Subject)
Oosthuizen Johannes Jacobus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
10:14 AM
Merck & Co., Inc. (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/11/2025
1:59 PM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:04 PM
BAKER DOUGLAS M JR (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:07 PM
Downing Cristal N (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:09 PM
Merck & Co., Inc. (Issuer)
THULIN INGE G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:43 PM
Downing Cristal N (Reporting)
Merck & Co., Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
5:45 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
5:29 PM
Merck & Co., Inc. (Issuer)
Zachary Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
5:17 PM
Downing Cristal N (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
5:19 PM
Li Dean Y (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
5:21 PM
Litchfield Caroline (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
5:23 PM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
5:25 PM
Merck & Co., Inc. (Issuer)
Smart Dalton (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
5:27 PM
Merck & Co., Inc. (Issuer)
Williams David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
5:07 PM
Guindo Chirfi (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
5:09 PM
Chattopadhyay Sanat (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
5:12 PM
Davis Robert M (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
5:14 PM
DeLuca Richard R. (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
12:53 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
12:55 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
12:57 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
11:59 AM
Karsanbhai Surendralal Lanca (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
11:55 AM
Karsanbhai Surendralal Lanca (Reporting)
Merck & Co., Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/23/2024
6:32 AM
Merck & Co., Inc. (Filed by)
Personalis, Inc. (Subject)
Form SCHEDULE 13G
12/23/2024
5:00 AM
Merck & Co., Inc. (Reporting)
MERCK SHARP & DOHME LLC (Reporting)
Personalis, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/22/2024
1:28 PM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:05 PM
Merck & Co., Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
3:09 PM
Evaxion Biotech A/S (Subject)
Merck & Co., Inc. (Filed by)
Form SC 13G/A
11/04/2024
9:05 AM
Merck & Co., Inc. (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
Form 25-NSE
10/31/2024
5:44 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
1:06 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
1:10 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
1:16 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
11:20 AM
Guindo Chirfi (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
5:41 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
12:20 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad)

We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.

But something even more spectacular is bound to happen. And those who know what to expect could make
07/02/2024
12:23 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
12:25 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
12:37 PM
Merck & Co., Inc. (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2024
12:37 PM
Merck & Co., Inc. (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2024
12:38 PM
Merck & Co., Inc. (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/04/2024
1:55 PM
Merck & Co., Inc. (Issuer)
Rothman Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:59 PM
Merck & Co., Inc. (Issuer)
Warden Kathy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
2:00 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
2:02 PM
Merck & Co., Inc. (Issuer)
RUSSO PATRICIA F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:41 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:44 PM
BAKER DOUGLAS M JR (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:44 PM
Merck & Co., Inc. (Issuer)
THULIN INGE G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:32 PM
Mayo Stephen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:34 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:38 PM
Craig Pamela J. (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
1:15 PM
LAVIZZO-MOUREY RISA J (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
3:39 PM
Merck & Co., Inc. (Filer)
Form CERT
05/20/2024
5:28 AM
Merck & Co., Inc. (Filer)
MSD Netherlands Capital B.V. (Filer)
Form 424B5
05/15/2024
10:31 AM
Merck & Co., Inc. (Filer)
MSD Netherlands Capital B.V. (Filer)
Form POSASR
05/06/2024
3:29 PM
Merck & Co., Inc. (Subject)
MIZELL STEVEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
3:15 PM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:17 PM
Li Dean Y (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:19 PM
Merck & Co., Inc. (Issuer)
Zachary Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2024
5:41 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
3:05 PM
Merck & Co., Inc. (Filer)
Form 10-K/A
04/11/2024
3:08 PM
Merck & Co., Inc. (Filer)
Form DEF 14A
04/11/2024
3:10 PM
Merck & Co., Inc. (Filer)
Form DEFA14A
04/11/2024
3:12 PM
Merck & Co., Inc. (Filer)
Form ARS
04/08/2024
12:56 PM
Larson Betty D (Reporting)
Merck & Co., Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NYSE:MRK) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners